BMEA net incomeQ2 2026-$8.33M
BMEA net income was -$8.33M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$20.74M a year earlier. For the full fiscal 2025 it was -$61.80M, compared with -$138.43M in fiscal 2024.
Biomea Fusion Inc. (BMEA) financials
For the twelve months ended Jun 30, 2026, Biomea Fusion Inc. reported -$32.54M of net income.
- Net income, TTM
- -$32.54M
- Cash
- $34.82M
- Market cap
- $43.2M
FY2019FY2025
FY2020FY2024
BMEA revenue and earnings growth
BMEA EPSQ2 2026-$0.12
BMEA diluted EPS was -$0.12 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$1.18.
BMEA free cash flowQ3 2025-$11.55M
BMEA free cash flow was -$11.55M in fiscal Q3 2025 (ended Sep 30, 2025), compared with -$25.40M a year earlier. For the full fiscal 2024 it was -$120.26M, compared with -$99.96M in fiscal 2023.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Research and development | $61.98M | $118.08M | $102.55M | $62.71M | $28.00M | $3.67M | $1.09M |
| Selling, general and admin | $19.33M | $25.98M | $23.59M | $20.92M | $13.67M | $1.66M | $103.0K |
| Operating income | -$83.51M | -$144.07M | -$126.14M | -$83.63M | -$41.67M | -$5.33M | -$1.20M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | - |
| Net income | -$61.80M | -$138.43M | -$117.25M | -$81.83M | -$41.57M | -$5.32M | -$1.20M |
| EPS, basic | -$1.18 | -$3.83 | -$3.44 | -$2.80 | -$1.74 | -$0.51 | -$0.20 |
| EPS, diluted | -$1.18 | -$3.83 | -$3.44 | -$2.80 | -$1.74 | -$0.51 | -$0.20 |
| Diluted shares | 52.2M | 36.1M | 34.1M | 29.3M | 23.9M | 10.5M | 6.1M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $55.81M | $58.65M | $176.87M | $112.25M | $146.09M | $61.70M | $239.0K |
| Short-term investments | - | - | - | $1.15M | $27.78M | - | - |
| Receivables | - | - | - | - | - | $16.0K | - |
| Current assets | $58.05M | $68.33M | $179.18M | $117.82M | $176.56M | $62.22M | - |
| Total assets | $58.57M | $79.94M | $199.93M | $129.31M | $185.71M | $62.53M | - |
| Current liabilities | $11.10M | $21.67M | $22.86M | $19.10M | $4.64M | $1.62M | - |
| Total liabilities | $29.02M | $28.36M | $30.69M | $20.77M | $6.92M | $1.62M | - |
| Shareholders' equity | $29.55M | $51.57M | $169.24M | $108.54M | $178.78M | $5.17M | -$21.0K |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$70.37M | -$119.89M | -$96.59M | -$62.42M | -$35.44M | -$4.46M | -$1.28M |
| Capital expenditures | - | $362.0K | $3.37M | $1.03M | $3.17M | $51.0K | - |
| Free cash flow | - | -$120.26M | -$99.96M | -$63.45M | -$38.61M | -$4.51M | - |
| Investing cash flow | - | -$362.0K | -$2.22M | $27.34M | -$33.35M | -$51.0K | - |
| Financing cash flow | $67.90M | $1.67M | $163.80M | $1.24M | $153.19M | $65.97M | $1.44M |
| Stock-based compensation | $9.52M | $19.09M | $14.13M | $10.34M | $6.23M | $322.0K | - |
Key ratios
Income statement
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $9.14M | $9.12M | $8.12M | $14.40M | $16.57M | $22.90M | $25.24M | $27.24M | $31.82M | $33.78M | $30.87M | $25.35M |
| Selling, general and admin | $3.62M | $3.65M | $3.60M | $4.20M | $4.71M | $6.82M | $4.83M | $6.79M | $7.07M | $7.28M | $6.46M | $5.77M |
| Operating income | -$12.77M | -$12.77M | -$11.72M | -$20.80M | -$21.28M | -$29.71M | -$30.07M | -$34.04M | -$38.90M | -$41.06M | -$37.33M | -$31.12M |
| Net income | -$8.33M | -$12.41M | $4.61M | -$16.41M | -$20.74M | -$29.26M | -$29.30M | -$32.79M | -$37.28M | -$39.06M | -$34.88M | -$28.43M |
| EPS, basic | -$0.12 | -$0.17 | - | -$0.27 | -$0.51 | -$0.80 | -$0.81 | -$0.91 | -$1.03 | -$1.09 | -$0.98 | -$0.80 |
| EPS, diluted | -$0.12 | -$0.17 | - | -$0.27 | -$0.51 | -$0.80 | -$0.81 | -$0.91 | -$1.03 | -$1.09 | -$0.98 | -$0.80 |
| Diluted shares | 72.4M | 72.3M | - | 59.8M | 40.6M | 36.6M | 36.3M | 36.2M | 36.0M | 35.9M | 35.8M | 35.7M |
Balance sheet
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $34.82M | $44.69M | $55.81M | $46.64M | $56.22M | $35.86M | $58.65M | $87.95M | $113.29M | $144.92M | $176.87M | $199.09M |
| Current assets | $36.43M | $46.32M | $58.05M | $49.44M | $64.66M | $44.69M | $68.33M | $93.60M | $116.29M | $147.57M | $179.18M | $202.50M |
| Total assets | $36.87M | $46.38M | $58.57M | $55.19M | $73.16M | $55.05M | $79.94M | $110.42M | $136.16M | $168.49M | $199.93M | $225.09M |
| Current liabilities | $10.48M | $9.29M | $11.10M | $15.56M | $17.57M | $19.82M | $21.67M | $27.57M | $25.16M | $25.25M | $22.86M | $16.21M |
| Total liabilities | $24.74M | $27.67M | $29.02M | $39.57M | $45.65M | $26.32M | $28.36M | $34.45M | $32.22M | $33.18M | $30.69M | $25.48M |
| Shareholders' equity | $12.14M | $18.72M | $29.55M | $15.62M | $27.51M | $28.74M | $51.57M | $75.97M | $103.95M | $135.31M | $169.24M | $199.61M |
Cash flow
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.03M | -$11.67M | -$13.94M | -$11.55M | -$19.21M | -$25.67M | -$30.00M | -$25.22M | -$32.64M | -$32.03M | -$22.84M | -$23.90M |
| Capital expenditures | - | - | - | $0 | $0 | $0 | $82.0K | $186.0K | $59.0K | $35.0K | $8.0K | $39.0K |
| Free cash flow | - | - | - | -$11.55M | -$19.21M | -$25.67M | -$30.09M | -$25.40M | -$32.70M | -$32.06M | -$22.84M | -$23.94M |
| Investing cash flow | $0 | $550.0K | - | $0 | $0 | $0 | -$82.0K | -$186.0K | -$59.0K | -$35.0K | -$8.0K | -$39.0K |
| Financing cash flow | - | - | $23.11M | $1.97M | $39.57M | $3.25M | $413.0K | $69.0K | $1.07M | $116.0K | $622.0K | $138.0K |
| Stock-based compensation | $1.59M | $1.58M | $1.84M | $1.94M | $2.57M | $3.17M | $4.49M | $4.74M | $4.84M | $5.02M | $3.86M | $3.60M |
Key ratios
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 3.47 | 4.98 | 5.23 | 3.18 | 3.68 | 2.25 | 3.15 | 3.39 | 4.62 | 5.84 | 7.84 | 12.49 |
Source: XBRL data Biomea Fusion Inc. files with the SEC, latest filing dated Aug 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
BMEA peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| BMEA | - | - | -$32.54M | - | $43.2M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.33T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $679.13B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $518.44B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $366.73B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $312.35B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $293.69B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.40B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $183.23B |
BMEA FAQ
4 questionsIs BMEA profitable?
No. Biomea Fusion Inc. reported a net loss of $32.54M for the twelve months ended Jun 30, 2026.How much cash and debt does BMEA have?
Biomea Fusion Inc. reported $34.82M in cash and cash equivalents on its most recent balance sheet in SEC filings.When did BMEA last report financial results?
The latest statements here come from Biomea Fusion Inc.'s 10-Q filed on Aug 5, 2026, covering the period ended Jun 30, 2026.Where does this BMEA financial data come from?
Quantisnow builds these statements from the structured XBRL data Biomea Fusion Inc. files with the SEC. It is provided for information only and is not investment advice.